1. Neurocognitive & Neurological Outcomes in Children, Adolescents & Young Adults with High-Risk SCD Who Have Undergone Familial Haploidentical (FHI) Allosct Utilizing CD34 Enrichment and T Cell Addback Following Myeloimmunoablative Conditioning (MAC) 
Suzanne Braniecki, Julie-An M. Talano, Theodore B. Moore, Rona Weinberg, Carolyn A. Keever-Taylor, Brenda Grossman, Lee Ann Baxter-Lowe, Susan K. Parsons, Erin Morris, Phyllis Brand, Sandra Fabricatore, Janet Ayello, Mildred Semidei-Pomales, Carmella van de Ven, Cori Abikoff, Shalini Shenoy, Robert McKinstry, Mitchell S. Cairo 
Biology of Blood and Marrow Transplantation 
Volume 23, Issue 3, Pages S221-S222 (March 2017)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
Biology of Blood and Marrow Transplantation  , S221-S222DOI: ( /j.bbmt )
Copyright © Terms and Conditions

3. Figure 2
Presence of cerebral vasculopathy pre- and post FHI AlloSCT utilizing CD34 enrichment and T-cell addback in high rish SCD patients.
Biology of Blood and Marrow Transplantation  , S221-S222DOI: ( /j.bbmt )
Copyright © Terms and Conditions